Elysium Health, Inc.

New York, NY

UEI
LKNYXE4L32P6
CAGE
820Z0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
434 Broadway, New York, NY 10013, USA
Website
elysiumhealth.com
Founded
2014
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of nicotinamide-riboside plus pterostilbene as a disease modifying osteoarthritis therapeutic… R41AR082748 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $283,071

Quick answers

Is Elysium Health, Inc. registered in SAM.gov?

Yes. Elysium Health, Inc.'s SAM.gov registration is active through January 12, 2027.

What is Elysium Health, Inc.'s most recent federal award?

Elysium Health, Inc.'s most recent federal grant award is Development of nicotinamide-riboside plus pterostilbene as a disease modifying osteoarthritis therapeutic… (R41AR082748), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on June 1, 2023.

On GovTribe

See Elysium Health, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login